EXORPHIA, INC.

EXORPHIA is a drug discovery startup that focuses on the potential of exosomes as new treatment options for intractable diseases. The company has developed proprietary core technologies in each process of culture, purification, analysis, and pharmacological evaluation and has established a technological foundation that enables mass production and quality control of exosomes at a pharmaceutical level. Utilizing exosomes' natural drug delivery capabilities, the company will generate solutions for unresolved health challenges, thereby committing to continuously enhancing corporate value.